National Health Investors (NHI) Common Equity (2009 - 2026)

National Health Investors' Common Equity history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• Quarterly Common Equity rose 6.1% year-over-year to $1.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.5 billion (up 6.1% YoY) and the FY2025 annual result came in at $1.5 billion, up 11.22% from the prior year.
• Common Equity was $1.5 billion for Q1 2026 at National Health Investors, roughly flat from $1.5 billion in the prior quarter.
• Across five years, Common Equity topped out at $1.5 billion in Q4 2025 and bottomed at $1.2 billion in Q3 2024.
• A 5-year average of $1.4 billion and a median of $1.3 billion in 2022 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity retreated 15.67% — and 2025, when it rose 20.27%.
• National Health Investors' Common Equity stood at $1.3 billion in 2022, then dropped by 1.23% to $1.3 billion in 2023, then advanced by 8.78% to $1.4 billion in 2024, then increased by 11.22% to $1.5 billion in 2025, then decreased by 0.46% to $1.5 billion in 2026.
• Business Quant data shows NHI's Common Equity at $1.5 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.5 billion in Q3 2025.